Vincristine sulfate NEW
| Price | $64 |
| Package | 20mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-05 |
Product Details
| Product Name: Vincristine sulfate | CAS No.: 2068-78-2 |
| Purity: 99.87% | Supply Ability: 10g |
| Release date: 2024/11/05 |
Product Introduction
Bioactivity
| 名稱 | Vincristine sulfate |
| 描述 | Vincristine sulfate is an alkaloidal natural product that binds to microtubule proteins and inhibits the formation of microtubules, thereby inhibiting mitosis in tumor cells. Vincristine sulfate is used as a microtubule destabilizing agent in research studies for the treatment of hematologic neoplasms such as leukemias and lymphomas, as well as in studies related to sarcomas in children. |
| 細(xì)胞實(shí)驗(yàn) | SH-SY5Y cells at a logarithmic phase were seeded in 96-well plates (at 2x10^6/l) and incubated for 12 h until cells formed a monolayer. Wells were randomly chosen for treatment groups and a control group. For the treatment groups, cells were incubated with 200 μl of cell culture medium containing 0.001, 0.01, 0.1, 1 or 10 μM of VCR. In the control group, cells were grown in 200 μl cell culture medium only. Cells were incubated for another 24, 48 and 72 h and then 20 μl of 5 g/l MTT (0.1 mg/l final concentration) was added to each well. After 4 h of incubation, the cell culture supernatant was removed, 150 μl of DMSO was added to each well and the plate was shaken for 10 min. The absorbance of each well was detected at 490 nm (A value) on an ELISA plate reader. The growth inhibition rate of VCR-treated cells was calculated as: Growth inhibition rate % = [(average A value of control group - average A value of VCR-treated group)/average A value of control group] x 100%. This experiment was performed in triplicates [2]. |
| 動(dòng)物實(shí)驗(yàn) | Vincristine (1?mg/ml) was diluted in saline and administered i.v. to wild-type and Mdr1ab/Mrp1 TKO mice, aged 10–14 weeks, at dose levels ranging between 0.125 and 4?mg/kg. Animals were monitored daily and killed when they lost more than 20% of their initial body weight. The MTD was defined as one dose step below the dose where more than one animal in that group had to be killed. Necropsies were performed in wild-type and Mdr1ab/Mrp1 TKO mice receiving vincristine at or near the MTD and killed 2 days later [5]. |
| 體外活性 | METHODS: Neuroblastoma cells SH-SY5Y were treated with Vincristine sulfate (0.001-10 μM) for 24-72 h. Cell viability was measured by MTT assay. RESULTS: Vincristine inhibited the proliferation of SH-SY5Y cells in a dose- and time-dependent manner, with IC50s of 0.113 μM, 0.078 μM, and 0.051 μM at 24, 48, and 72 h, respectively. [1] METHODS: Human leukemia cells MOLT-4 were treated with Vincristine sulfate (0.3-3 μM) and SAHA (500 nM) for 24-48 h. Cell cycle was detected using Flow cytometry. RESULTS: Vincristine treatment induced an increase in the G2/M phase of the cell cycle compared to SAHA. the combination of Vincristine plus SAHA resulted in almost complete cell arrest in the G2/M phase after short-term treatment (24 h), followed by induction of the cells into the sub-G1 phase after long-term treatment (48 h). the combination of Vincristine and SAHA resulted in an increase in the G2/M phase of the cell cycle compared to SAHA. [2] |
| 體內(nèi)活性 | METHODS: To assay antitumor activity in vivo, Vincristine sulfate (0.025 mg/kg, intravenously, once weekly) and SAHA (200 mg/kg, orally, once daily) were administered to SCID mice bearing MOLT-4 xenografts for 24 days. RESULTS: TGD did not improve in mice treated with Vincristine or SAHA alone. However, log-rank analysis showed that co-treatment exhibited significant anti-tumor activity in the MOLT-4 xenograft model. [2] |
| 存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 50 mg/mL (54.17 mM) Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : 92.3 mg/mL (100 mM) |
| 關(guān)鍵字 | Inhibitor | Microtubule/Tubulin | NSC-67574 | Vincristine | Vincristine sulfate | Vincristine Sulfate | 22-Oxovincaleukoblastine | Apoptosis | NSC67574 | Leurocristine Sulfate | inhibit | NSC 67574 | 22-Oxovincaleukoblastine Sulfate |
| 相關(guān)產(chǎn)品 | Stavudine | 5-Fluorouracil | Myricetin | Meclizine dihydrochloride | Dextran sulfate sodium salt (MW 4500-5500) | Sodium 4-phenylbutyrate | L-Ascorbic acid | Metronidazole | Sorafenib | Tributyrin | Salicylic acid | Oleic acid |
| 相關(guān)庫(kù) | 中藥單體化合物庫(kù) | 經(jīng)典已知活性庫(kù) | 生物堿類天然產(chǎn)物庫(kù) | 植物來(lái)源化合物庫(kù) | 抗癌臨床化合物庫(kù) | 天然產(chǎn)物庫(kù) | FDA 上市藥物庫(kù) | 高通量篩選天然產(chǎn)物庫(kù) | 抗癌上市藥物庫(kù) | 抗癌活性化合物庫(kù) |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $64.00/20mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-05 | |
| $0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-10-14 | |
| $1.00/1g |
VIP1Y
|
S&Y Biochem Co.,Ltd
|
2024-08-01 | |
| $0.00/25kg |
VIP1Y
|
Hebei Mojin Biotechnology Co.,Ltd
|
2024-07-31 | |
| $25.00/1kg |
VIP2Y
|
Wuhan Quanjinci New Material Co.,Ltd.
|
2023-12-07 | |
| $0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-09-08 | ||
| $20.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 | ||
| $0.00/1Kg |
VIP3Y
|
Changzhou Rokechem Technology Co., Ltd.
|
2023-06-29 | |
| $1.00/1KG |
Weijer International Trade (Hebei) Co., Ltd
|
2023-03-23 | ||
| $1.00/1mg |
ANHUI SHENGZHIKAI BIOTECHNOLOGY CO.,LTD
|
2022-07-12 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY